Crowdsourcing for clinical trials and to enhance medical diagnosis
Medical crowdsourcing enables effective collaboration on everything from diagnosis to clinical trials.
The power of patient voice in clinical trial design
The increased patient-centric focus in drug development by the FDA is highly encouraging and expected to become more mainstream and legislated.
The Power of Real World Data to Study Women’s Health at Scale
Veradigm examines key clinical trends, comorbidity profiles, and treatment trends across adolescence, reproductive years, and peri-/post-menopause. Download it today!
Why do many IVD companies face an uphill battle with payers for reimbursement?
Despite the relative paucity of peer-reviewed studies for IVDs in general, several companies are taking steps to publish their data, which can ultimately lead to positive coverage decisions by payers
Risk-based IVD regulations: What do they mean for the global IVD industry?
In vitro diagnostics, particularly lab-developed tests, designed for precision medicine may be among those impacted the most by risk-based frameworks, both overseas and in the U.S.
The MoneyBall solution to the healthcare crisis
In virtually every other industry, the use of data analytics has been revolutionary, allowing companies to optimize their product and procedures.
What’s the key to efficient IVD development?
A look at the advantages of different engineering models that in vitro diagnostic companies should consider adopting to improve production.
The Hidden Administrative Tasks Draining Small Practices
Small practices play a critical role in healthcare delivery, but they cannot continue to absorb ever-increasing administrative demands without consequences.
IVDs and data requirements in a value-based reimbursement landscape
Because in vitro diagnostics are so integral to patient care, particularly for oncology, developers must be aware of how quality and efficacy data pertaining to their device will be used.
This is why pre-design research is essential for the IVD industry
Which in vitro diagnostics are filling providers’ needs? Are they deficient in a performance characteristic that your IVD will improve upon or have you developed a new method that is more cost-efficient?
How can the in vitro diagnostics industry tap the growth potential of integrated delivery networks?
Global demand for home healthcare services will exceed a market value of $391 billion by 2021. Diagnostics equipment, including IVDs, account for more than one-third of the overall home healthcare equipment market and that share is expected to grow.
Learning from failure: What Theranos, Interleukin Genetics, & Courtagen can teach us about IVDs
Realistic expectations are essential when forecasting both the adoption of the device and the length of time needed for payers to reimburse for the test to ensure adequate working capital, writes Harry Glorikian.
presented by
Inside an Automated Healthcare Practice: Redesigning Care Around People, Not Paperwork
By reducing administrative burden and redesigning workflows around human needs, it creates space for what matters most: connection between clinicians and patients.